Sanchez-Ruiz, Jorge A. http://orcid.org/0000-0003-4282-7359
Coombes, Brandon J. http://orcid.org/0000-0003-4322-5923
Pazdernik, Vanessa M. http://orcid.org/0000-0001-7566-7334
Melhuish Beaupre, Lindsay M.
Jenkins, Greg D. http://orcid.org/0000-0001-6408-6227
Pendegraft, Richard S.
Batzler, Anthony
Ozerdem, Aysegul http://orcid.org/0000-0002-9455-5896
McElroy, Susan L.
Gardea-Resendez, Manuel A.
Cuellar-Barboza, Alfredo B.
Prieto, Miguel L.
Frye, Mark A. http://orcid.org/0000-0001-6997-4215
Biernacka, Joanna M. http://orcid.org/0000-0001-9350-4440
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH121924, R01MH121924, R01MH121924, R01MH121924, R01MH121924, R01MH121924, R01MH121924, R01MH121924, R01MH121924, R01MH121924, R01MH121924, R01MH121924, R01MH121924)
Marriott Foundation Thomas and Elizabeth Grainger Fund in Bipolar Functional Genomics and Drug Development Mayo Clinic Center for Individualized Medicine
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 12 July 2023
Revised: 21 February 2024
Accepted: 13 March 2024
First Online: 28 March 2024
Competing interests
: SLM reports receiving personal fees for advisory boards and/or consultation from Idorsia, Levo, Novo Nordisk, Otsuka, Sunovion, and Takeda; receiving grant support from Idorsia, Janssen, Marriott Foundation, Myriad, National Institute of Mental Health, Novo Nordisk, Otsuka, and Sunovion; and receiving payments from Johnson & Johnson for being an inventor on US Patent No. 6,323,236 B2. ABCB has received lecture and consulting fees from Asofarma and Exeltis. MLP has served on an advisory board for Janssen and has received grant support from ANID FONDECYT Regular 1181365, FONDEF ID19I10116 and Basal Funding for Scientific and Technological Center of Excellence, IMPACT, #FB210024. MAF reports the following conflicts of interest: grant support from Assurex Health and Mayo Foundation; CME/travel/honoraria from Carnot Laboratories, American Physician Institute; and financial interest/stock ownership/royalties in Chymia LLC. All other authors declare no competing interests.